Psychopharmacological Treatment of Major Depressive Disorder in Children and Adolescents
- 27 August 2003
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 290 (8) , 1091-1093
- https://doi.org/10.1001/jama.290.8.1091
Abstract
Opinion from JAMA — Psychopharmacological Treatment of Major Depressive Disorder in Children and AdolescentsKeywords
This publication has 7 references indexed in Scilit:
- Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive DisorderTwo Randomized Controlled TrialsJAMA, 2003
- Suicide Rates in Clinical Trials of SSRIs, Other Antidepressants, and Placebo: Analysis of FDA ReportsAmerican Journal of Psychiatry, 2003
- Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Sudden Death Related to Selected Tricyclic Antidepressants in ChildrenPediatric Drugs, 2001
- A Double-blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Children and Adolescents With DepressionArchives of General Psychiatry, 1997
- Childhood and Adolescent Depression: A Review of the Past 10 Years. Part IJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Depression in Young People: Initial Presentation and Clinical CourseJournal of the American Academy of Child & Adolescent Psychiatry, 1993